Change in plasma cryptococcal antigen titer is not associated with survival among human immunodeficiency virus–infected persons receiving preemptive therapy for asymptomatic cryptococcal antigenemia
Change in plasma cryptococcal antigen titer is not associated with survival among human immunodeficiency virus–infected persons receiving preemptive therapy for asymptomatic cryptococcal antigenemia
Date
2019
Authors
Pullen, Matthew F.
Kakooza, Francis
Nalintya, Elizabeth
Kiragga, Agnes N.
Morawski, Bozena M.
Morawski, Bozena M.
Rajasingham, Radha
Mubiru, Anthony
Manabe, Yukari C.
Kaplan, Jonathan E.
Journal Title
Journal ISSN
Volume Title
Publisher
Oxford Academic Press
Abstract
Description
Keywords
Plasma cryptococcal antigen titer,
Human Immunodeficiency Virus survivors,
Preemptive therapy,
Asymptomatic cryptococcal antigenemia
Citation
Pullen, M. F. et al. (2019). Change in plasma cryptococcal antigen titer is not associated with survival among human immunodeficiency virus–infected persons receiving preemptive therapy for asymptomatic cryptococcal antigenemia, Clinical Infectious Diseases, 70(2), 1-3.